When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

"Our results identify potentially disease-facilitating bacteria sampled from the ileum of multiple sclerosis affected twins," ...

Source Reference: Vitkova M, et al "Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis: an international registry study" Neurology 2022; DOI: 10. ...

Epstein-Barr Virus Epstein-Barr virus (EBV) has long been postulated to play a role in the pathogenesis of MS, but that connection received a solid boost in 2022, when Alberto Ascherio, MD, DrPH ...

His research shows molecular changes in brain cells when a person develops multiple sclerosis (MS). But it is still unclear ...

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

The study also confirmed already known risk factors, including a family history of the disease, an infection with the Epstein-Barr virus and being overweight or obese as a child or adolescent.

Scientists at Sweden’s Karolinska Institutet have made a major breakthrough in understanding how a common virus could be linked to multiple sclerosis (MS), a serious disease that affects the ...

Scientiam Pharma has disclosed new 6-aminophenanthridine derivatives acting as Epstein-Barr nuclear antigen 1 (EBNA-1) inhibitors reported to be useful for the treatment of Epstein-Barr virus ...

The following is the transcript of an interview with former FDA commissioner Scott Gottlieb, Pfizer board member and ...

Celebrating independence can be important when living with multiple sclerosis, columnist Ben Hofmeister writes.